Evolution Advisers Inc. Takes Position in Nutrien Ltd. (NYSE:NTR)

Evolution Advisers Inc. acquired a new stake in shares of Nutrien Ltd. (NYSE:NTRFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 867 shares of the company’s stock, valued at approximately $49,000.

Other institutional investors and hedge funds have also modified their holdings of the company. The Manufacturers Life Insurance Company boosted its stake in Nutrien by 51.3% in the third quarter. The Manufacturers Life Insurance Company now owns 6,853,165 shares of the company’s stock worth $425,881,000 after purchasing an additional 2,322,679 shares in the last quarter. ANTIPODES PARTNERS Ltd boosted its stake in Nutrien by 18,312.9% in the fourth quarter. ANTIPODES PARTNERS Ltd now owns 1,595,295 shares of the company’s stock worth $89,862,000 after purchasing an additional 1,586,631 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in Nutrien by 544.3% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,361,282 shares of the company’s stock worth $84,794,000 after purchasing an additional 1,150,000 shares in the last quarter. TD Asset Management Inc raised its position in shares of Nutrien by 15.0% during the third quarter. TD Asset Management Inc now owns 7,175,994 shares of the company’s stock worth $445,187,000 after acquiring an additional 933,517 shares during the last quarter. Finally, FMR LLC raised its position in shares of Nutrien by 15.4% during the third quarter. FMR LLC now owns 6,369,027 shares of the company’s stock worth $393,325,000 after acquiring an additional 849,908 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. BMO Capital Markets dropped their target price on Nutrien from $86.00 to $80.00 and set an “outperform” rating for the company in a research report on Thursday, January 25th. The Goldman Sachs Group dropped their price objective on Nutrien from $88.00 to $78.00 and set a “buy” rating for the company in a report on Thursday, February 1st. Royal Bank of Canada dropped their price objective on Nutrien from $75.00 to $70.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Wolfe Research assumed coverage on Nutrien in a report on Friday, March 1st. They issued an “outperform” rating and a $66.00 price objective for the company. Finally, Stifel Nicolaus upped their price objective on Nutrien from $72.00 to $75.00 and gave the company a “buy” rating in a report on Friday, January 19th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $67.95.

Get Our Latest Analysis on Nutrien

Nutrien Stock Down 0.5 %

NYSE NTR traded down $0.24 during trading hours on Thursday, hitting $52.05. 1,536,359 shares of the company traded hands, compared to its average volume of 1,997,104. The business’s 50-day moving average is $53.20 and its 200-day moving average is $54.15. Nutrien Ltd. has a twelve month low of $47.90 and a twelve month high of $70.07. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.65 and a current ratio of 1.17. The stock has a market capitalization of $25.74 billion, a price-to-earnings ratio of 20.57, a P/E/G ratio of 1.95 and a beta of 0.89.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings results on Wednesday, February 21st. The company reported $0.37 EPS for the quarter, missing the consensus estimate of $0.72 by ($0.35). Nutrien had a net margin of 4.33% and a return on equity of 8.59%. The company had revenue of $5.66 billion for the quarter, compared to analyst estimates of $5.36 billion. During the same period last year, the company posted $2.02 earnings per share. The business’s revenue for the quarter was down 24.8% on a year-over-year basis. Sell-side analysts anticipate that Nutrien Ltd. will post 3.82 earnings per share for the current year.

Nutrien Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 11th. Stockholders of record on Thursday, March 28th were given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 4.15%. This is a boost from Nutrien’s previous quarterly dividend of $0.53. The ex-dividend date was Wednesday, March 27th. Nutrien’s dividend payout ratio (DPR) is presently 85.38%.

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.